Anthony Traboulsee

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Dean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett et al. · Neurology · 2015 · 4.5K citations · Full text

Medicine, Neurology, Neuroscience +15

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Stephen L. Hauser, Amit Bar‐Or, Gavin Giovannoni et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

Life Sciences, Immunology, Neurology +17

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos et al. · New England Journal of Medicine · 2016 · 1.9K citations · Full text

Life Sciences, Immunology, Neurology +17

Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology

Cornelia Laule, Esther Leung, D. K. B. Li et al. · Multiple Sclerosis Journal · 2006 · 492 citations

Medicine, Neurology, Neuroscience +17

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

Anthony Traboulsee, Benjamin Greenberg, Jeffrey L. Bennett et al. · The Lancet Neurology · 2020 · 490 citations · Full text

Medicine, Neurology, Pharmacotherapy +5